Drugs / Vecam
last change Jun 2009 re-read 2 minutes ago

Vecam

Developed for
gastroesophageal reflux disease
Investigated by
Vecta Ltd.

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00818870 Dec 2008 → Jun 2009 gastroesophageal reflux disease Vecta Ltd. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vecam ClinicalTrials.gov intervention name — accepted as the source's own label NCT00818870